Rate My Professor Catherine Stedman

Stedman's research specializations encompass liver disease and pharmacology, with primary focus on hepatitis C antiviral therapies and autoimmune liver diseases. She has led as principal investigator in over 60 clinical trials, including the world's first demonstration of hepatitis C cure using a short course of oral antivirals and pioneering trials in decompensated cirrhosis patients, despite challenges from the Christchurch earthquakes. Her epidemiological studies examine incidence trends, morbidity, and mortality of autoimmune liver conditions like primary sclerosing cholangitis in New Zealand populations. Stedman received the Gold Medal in Research from the University of Otago Christchurch in 2019 and serves as President of the New Zealand Society of Gastroenterology. Key publications include 'Trends in Incidence of Autoimmune Liver Diseases and Increasing Mortality in Primary Sclerosing Cholangitis' (Clinical Gastroenterology and Hepatology, 2021), contributions to sofosbuvir-based HCV treatment reviews (2014), and global hepatitis C prevalence modeling (The Lancet Gastroenterology & Hepatology, 2017). Her 118 research outputs have garnered over 10,000 citations, influencing World Health Organization strategies for hepatitis C elimination.